Literature DB >> 7513096

Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs.

R W Gruessner1, R Nakhleh, P Tzardis, R Schechner, J L Platt, A Gruessner, G Tomadze, J S Najarian, D E Sutherland.   

Abstract

Clinical observations suggest that recipients of multiorgan transplants from the same donor can have disparate immunological reactions to each organ. We studied this phenomenon in 36 diabetic (streptozotocin-induced), bilaterally nephrectomized, immunosuppressed (cyclosporine, azathioprine, prednisone) pig recipients of simultaneous (same donor) pancreas (bladder drained) and kidney allografts by grading the histological intensity of rejection in biopsies of each organ at defined intervals posttransplant. Graft function was monitored by plasma glucose (PG) and urine amylase (UA) for the pancreas and serum creatinine (Cr) for the kidney. Interstitial rejection was graded as absent, mild, moderate, and severe in, respectively, 8%, 25%, 42%, and 25% of pancreas vs. 4%, 12%, 27%, and 57% of kidney biopsies at 1 week; and 0%, 43%, 29%, and 29% of pancreases vs. 10%, 0%, 30%, and 60% of kidneys at two weeks. Although the distribution of grades was similar in the two organs (P > 0.1), the grade of rejection for each pair at 1 week (n = 24) was discordant in 75% (42% differed by one and 33% by > or = 2 grades) and at 2 weeks (n = 7) in 57% (29% by 1 and 29% by > or = 2 grades). The inability to use the severity of interstitial rejection in one organ to predict the findings in the other is exemplified by the fact that for the two pancreases without interstitial rejection at one week, the corresponding kidney showed moderate or severe rejection, and for the 1 kidney without rejection the corresponding pancreas showed moderate rejection. Vascular rejection grades (absent, mild, moderate, severe) also showed a similar distribution for the pancreas (57%, 30%, 9%, 4%) vs. kidney (50%, 38%, 0%, 12%) at 1 week, and at 2 weeks (57%, 29%, 0%, and 14% for the pancreas vs. 78%, 11%, 0%, and 11 for the kidney) (P > or = 0.64). However, the grading of vascular rejection in organ pairs was dyssynchronous in 54% at 1 week (n = 22) and 29% at 2 weeks (n = 7). No vascular rejection in the pancreas with rejection in the kidney was seen in 5 pairs at 1 week (23%) and 0 at 2 weeks (0%), while no rejection in the kidney with rejection in the pancreas was seen in 5 pairs at 1 week (23%) and 2 pairs at 2 weeks (29%).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513096

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Establishment of a pig model of combined pancreas-kidney transplantation.

Authors:  Ze-Kuan Xu; Xun-Liang Liu; Wei Zhang; Yi Miao; Jing-Hui Du
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

2.  Isolated pancreas rejections do not have an adverse impact on kidney graft survival whereas kidney rejections are associated with adverse pancreas graft survival in simultaneous pancreas kidney transplantation.

Authors:  Irfan Moinuddin; Muhammad Sohail Yaqub; Tim Taber; John Powelson; Jonathan Fridell; Asif Sharfuddin
Journal:  J Nephrol       Date:  2017-09-16       Impact factor: 3.902

Review 3.  Pancreas transplantation.

Authors:  R J Stratta; R J Taylor; J L Larsen; K Cushing
Journal:  Int J Pancreatol       Date:  1995-02

4.  Simultaneous pancreas-kidney transplantation from live donors.

Authors:  R W Gruessner; D M Kendall; M B Drangstveit; A C Gruessner; D E Sutherland
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

5.  Establishment of a pig model with enteric and portal venous drainage of pancreatoduodenal transplantation.

Authors:  Zhao-Da Zhang; Fang-Hai Han; Ling-Xiang Meng
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

6.  Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy.

Authors:  S T Bartlett; E J Schweitzer; L B Johnson; P C Kuo; J C Papadimitriou; C B Drachenberg; D K Klassen; E W Hoehn-Saric; M R Weir; A L Imbembo
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.